Literature DB >> 10972223

Beneficial effect of HLA-DR matching on the survival of corneal allografts.

H J Völker-Dieben1, F H Claas, G M Schreuder, R F Schipper, E Pels, G G Persijn, J Smits, J D'Amaro.   

Abstract

BACKGROUND: Although HLA typing and matching have been used for 3 decades, that practice has been poorly implemented in corneal transplantation, mainly because of inconclusive or contradictory analytical results. Consequently, we studied the immune response of corneal transplant recipients to HLA histoincompatibilities in a large homogeneous study.
METHODS: All corneal transplantations performed by a single surgeon between 1976 and 1996 were studied. HLA-AB matching was used for recipient selection. All HLA typings were performed by a single experienced laboratory. Population genetic techniques were used to assess the validity of the HLA typings. Mono- and multivariate analyses were performed to identify the factors which significantly influence the survival of corneal allografts. Simulation studies were carried out to demonstrate the effects of mis-typed donor and recipient HLA-DR typings on analytical results.
RESULTS: Retransplantation, degree of vascularization, HLA-AB and DR matching, endothelial cell count, graft size, recipient gender, and storage method were identified as significant factors by our monovariate analyses. A Cox proportional hazards survival analysis model identified degree of vascularization and HLA-AB and DR matching as significant prognostic factors when all immunological rejection episodes were used, P=0.000001. When only irreversible immunological rejection episodes were used, panel reactive antibodies, retransplantation, and number of rejection events were also identified, P=0.000001. Simulation studies showed that the effects of HLA-DR matching are abrogated by poor HLA-DR typings.
CONCLUSIONS: Corneal allograft recipients have a normal alloimmune response to histoincompatibilities. Demonstration of that fact requires accurate HLA typings.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10972223     DOI: 10.1097/00007890-200008270-00018

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  17 in total

Review 1.  [Tissue typing in perforating corneal transplantation].

Authors:  J Wachtlin; R Khaireddin; F Hoffmann
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

2.  [Current practice of immune prophylaxis and therapy in perforating keratoplasty. A survey of members of the Cornea Section of the German Ophthalmological Society].

Authors:  E Bertelmann; T Reinhard; U Pleyer
Journal:  Ophthalmologe       Date:  2003-12       Impact factor: 1.059

3.  [Immune reactions to posterior lamellar versus penetrating keratoplasty. A retrospective analysis].

Authors:  E Bertelmann; C Seeger; P Rieck; N Torun
Journal:  Ophthalmologe       Date:  2012-03       Impact factor: 1.059

4.  Rejection Prophylaxis in Corneal Transplant.

Authors:  Daniel Böhringer; Birgit Grotejohann; Gabriele Ihorst; Helga Reinshagen; Eric Spierings; Thomas Reinhard
Journal:  Dtsch Arztebl Int       Date:  2018-04-13       Impact factor: 5.594

Review 5.  [Typing for HLA matching. Advantages for keratoplasty].

Authors:  R Ignatius; F Hoffmann
Journal:  Ophthalmologe       Date:  2007-03       Impact factor: 1.059

6.  [ABO blood group expression in corneal allograft failures].

Authors:  N Ardjomand; P Komericki; A Klein; D Mattes; Y El-Shabrawi; H Radner
Journal:  Ophthalmologe       Date:  2005-10       Impact factor: 1.059

Review 7.  Management of high-risk corneal transplantation.

Authors:  Antonio Di Zazzo; Ahmad Kheirkhah; Tulio B Abud; Sunali Goyal; Reza Dana
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

8.  IFN-γ blocks CD4+CD25+ Tregs and abolishes immune privilege of minor histocompatibility mismatched corneal allografts.

Authors:  K Cunnusamy; J Y Niederkorn
Journal:  Am J Transplant       Date:  2013-10-01       Impact factor: 8.086

9.  Clinical presentation, risk factors and treatment outcomes of first allograft rejection after penetrating keratoplasty in early and late postoperative period.

Authors:  C Perera; V Jhanji; E Lamoureux; G Pollock; I Favilla; R B Vajpayee
Journal:  Eye (Lond)       Date:  2012-02-17       Impact factor: 3.775

10.  HLA-A, HLA-B and HLA-DR matching reduces the rate of corneal allograft rejection.

Authors:  Riad Khaireddin; Joachim Wachtlin; Werner Hopfenmüller; Friedrich Hoffmann
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-08-29       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.